Matt Layton, MD, PhD

  1. Interim Vice Chair, Psychiatry


  • University of Kansas, PhD in pharmacology
  • University of Kansas, MD



  • University of Kansas, PhD in pharmacology
  • University of Kansas, MD


Medical Director

  • College of Nursing Program of Excellence in Addictions Research
  • Sleep and Performance Research Center


Matt Layton, PhD, is involved in training rural primary care doctors, physician assistants and nurses to work with patients who have psychiatric disorders and drug addictions.


Dr. Layton is the physician of record and co-investigator in the WSU Sleep and Performance Research Center. His current research interests include Addictions, Opioids, Pain, Hyperbaric Oxygen Treatment, Natural Products and Drug Interactions, and using Sleep Technology to study the impact of substances of abuse.

Research Funding (Active)

DOD Army (Hansen): 1/1/2022-12/31/2023
Realigning Circadian Rhythms to Improve Glucose Metabolism, Mitigate Metabolic Harm and Confer Resilience during Shift Work and Transmeridian Travel
Role: Co-Investigator

NCI CA252185  (McPherson): 5/1/21 – 4/30/26
An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder
Role: Co-Investigator

Google (Hansen): 6/1/2021-9/30/2022
Objective Fatigue Measurement with Phone-Based Eye Tracking
Role: Co-Investigator

JAZZ PHARMA (Hansen): 9/10/2021-8/31/2022
Solriamfetol’s Effect on Cognitive Health in Apnea Participants
Role: Co-Investigator

DOD Navy (Honn): 1/27/2021-8/26/2022
Circadian Entrainment and Performance Recovery
Role: Co-Investigator

MED TECH ENT CONSORT (Honn): 11/16/2021-9/15/2024
Sustaining and Enhancing Post Mission Analysis of Side-Scan Sonar Data
Role: Co-Investigator

HHS/NIH (Prasad): 9/27/2021-7/31/2022
Ontogeny of Drug Transport
Role: Co-Investigator

NCCIH (Paine): 9/1/2021-8/31/2022
Natural Product-Drug Interaction Research: The Roadmap to Best Practices
Role: Co-Investigator

Ellevet Sciences (Paine): 9/24/2021-4/30/2023
Human pharmacokinetic study with Tevelle Soft Gels
Role: Co-Investigator

NIAAA AA028796 (McPherson): 09/15/20 – 07/31/25
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
Role: Co-Investigator

HHS/NIH 12H-5520-2073 (DeWitt): 7/1/2019-6/30/2024
Rethinking Education on Substance use through inter-Professional Education and Rural Community Training (RESPECT)
Role: Co-Investigator

Additional Info

Matt Layton, PhD, is a psychiatrist and served as chair of the Elson S. Floyd College of Medicine curriculum committee for nearly four years under the founding bylaws. He works to incorporate lessons about human behavior into both the pre-clerkship and clerkship phases of the medical school curriculum.  He helps prospective doctors understand how the way people behave affects their health. He is also the medical director for the WSU College of Nursing’s Program of Excellence in the Addictions.

Layton is a Kansas native who was medical director for Spokane Mental Health for eight years. Since coming to WSU Spokane in the fall of 2008, he has won ‘Outstanding Faculty’ awards given by the UW physician assistant program, first-year Spokane medical students, and was named preceptor of the year for the Family Medicine Spokane Residency Program.


Dr. Layton talks about exporting mental health treatment to rural areas

WSU News Story

Mental health training looks at whole person